- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE’s SPECT System Gets FDA Clearance
GE Healthcare’s advanced single head nuclear medicine gamma camera with SPECT capability has received FDA clearance.
GE Healthcare’s advanced single head nuclear medicine gamma camera with SPECT capability has received FDA clearance, the company announced.
The Brivo NM615, designed as a cost-effective way to perform routine scanning while expanding their capabilities, allows doctors to lower injected patient dose by up to 50 percent of those of standard nuclear medicine scanning protocols, or the potential for patients to spend less time on the exam table, without compromising image quality, according to the company.
The system has a 70 cm wide bore and table capable of handling patients up to 500 pounds. The Brivo NM 615 can also be upgraded on site to the GE Healthcare Discover NM630 or the Discovery NM/CT 670 SPECT/CT hybrid systems. As a result, the system may expand the capability to serve patients in the future at faster speeds and with SPECT/CT hybrid scans.
Brivo NM615 can be used with the advanced Xeleris workstation, which integrates new and existing nuclear medicine equipment, including legacy GE and non-GE devices.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
